TPD52 and familial pancreatic carcinoma: To address this, a larger number of cases need to be included in later clinical work to further investigate the prognostic relationship between expression levels of TPD52 and miR-133a and patients with pancreatic cancer, the mechanism of TPD52 and miR-133a in the occurrence and development of pancreatic cancer also needs further study.